Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
A Study of Azithromycin in HIV-Infected Patients Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on A Study of Azithromycin in HIV-Infected Patients conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. A Study of Azithromycin in HIV-Infected Patients Clinical research trials and A Study of Azithromycin in HIV-Infected Patients medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like A Study of Azithromycin in HIV-Infected Patients. A Study of Azithromycin in HIV-Infected Patients Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a A Study of Azithromycin in HIV-Infected Patients clinical trial. Participants frequently obtain the most expert healthcare available for their A Study of Azithromycin in HIV-Infected Patients condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "A" Clinical Trials Conditions > A Study of Azithromycin in HIV-Infected Patients

A Study of Azithromycin in HIV-Infected Patients



A Study of Azithromycin in HIV-Infected Patients

For Condition: Bacterial Infections,HIV Infections
Status: Completed
Sponsor(s): Pfizer ,
Synopsis: To assess the dose proportionality of azithromycin concentrations and toleration when delivered in tablet formulation to HIV-infected patients. The need exists to further assess the antibacterial agent azithromycin at differing doses in an HIV-infected population.
Details: The need exists to further assess the antibacterial agent azithromycin at differing doses in an HIV-infected population. Patients are randomized to receive azithromycin at 1 of 2 doses in a two-treatment, two-period, cross-over study. Dosing visits are separated by at least 14-day wash-out periods.
Eligibility:
Study Type:  Interventional, Treatment, Parallel Assignment
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: - HIV seropositivity. - CD4 count <= 500 cells/mm3. - NO active AIDS opportunistic infection. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: - Other active intercurrent illness. - Any condition possibly affecting drug absorption (e.g., ulcers, gastrectomy, HIV-associated enteropathies. - Signs or symptoms of severe illness that would preclude study participation. - Known allergies to macrolide antibiotics. Patients with the following prior condition are excluded: Clinically important change in baseline status within 4 weeks prior to study entry. Prior Medication: Excluded: - Investigational drugs including treatment IND drugs within 4 weeks prior to study entry. Known drug or alcohol dependence.
Total Enrollment: 12

Location and Contact Information:

Harris Laboratories Inc
Phoenix,  Arizona,  85040
United States
 


Additional Information:
Study ID Numbers:  226C;  066-060
Study Start Date: 
Record last reviewed: April 1996
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002344

Other Hiv Infections Studies:
1. Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites

2. New antibiotic to treat pediatric patients with infections due to a specific bacteria (Vancomycin-Resistant Enterococcus)

3. A Study of Azithromycin in HIV-Infected Patients

4. Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis

5. Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.

Related Studies:

Other HIV Infections Clinical Trials
Other Arizona Clinical Trials
Other Phoenix Clinical Trials

A Study of Azithromycin in HIV-Infected Patients
Modify your Search

  Other HIV Infections Clinical Trials
  Other Arizona Clinical Trials
  Other Phoenix Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103